课题基金 / 基金详情

Studies for developing a laboratory diagnostic system for cancers by means of PCR that is applicale to clinical samples such as urine and stool

Studies for developing a laboratory diagnostic system for cancers by means of PCR that is applicale to clinical samples such as urine and stool
研究开发适用于尿液和粪便等临床样本的 PCR 癌症实验室诊断系统
批准号:
05557059
负责人:
WATANABE Toshiki
金额:
$10.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

WATANABE Toshiki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project, we studied the following points : (1)Simple methods extracting DNA from clinical materials such as urine and stool. (2)Prevention of carry-over contamination of PCR products. (3)Detection of point mutaion by non-radioisotpoe probes. (4)New method for detecting point mutation ocurring at random position. As for the method of DNA extraction, we compared 4 methods including commercial glass beads method. Our results indicated that the glass beads method with a minor modification was very simple and worked efficiently, and the DNA sample obtained was good for PCR analysis. For preventing the carry-over contamination, we tested the Uracyl N-glycosylase system. It was confirmed that dUTP-Uracyl N-glycosylase system can be the only practical method to prevent carry-over contamination in the PCR performed in the conventional laboratories not specificaly equipped for PCR studies. We tried to detect a point mutation in the Ki-ras gene from clinical samples using non-radioisotope probes. Chemiluminescence system proved to be suitable for this purpose, because other staining method resulted in high background signals. We also tried to establish a new method for detecting a point mutaion ocurring at a random position. The first plan was based on the specific digestion by S1 nuclease of the heteroduplex formed by wild type and mutated genes after hybridization. It was revealed that S1 nuclease digestion was not specific enough for our purpose. Trials of other methods are now under way.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HTLV-1 hijacks T-cell differentiation/function by deregulatingHelios gene expression
  • 批准号:
    23659484
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2011
  • 负责人:
    WATANABE Toshiki
  • 依托单位:
Oncogene addiction of ATL cells and abnormal Polycomb-miRNA-signal transduction
  • 批准号:
    23390250
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.4万
  • 财政年份:
    2011
  • 负责人:
    WATANABE Toshiki
  • 依托单位:
Pursuit of a new system for a high throughput screening of drugs to develop a new strategy of prevention and treatment of ATL
  • 批准号:
    20390267
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.06万
  • 财政年份:
    2008
  • 负责人:
    WATANABE Toshiki
  • 依托单位:
Abnormalities in TCR signal transduction in T cell non-Hodgkin's lymphoma as a basis for a new classification system.
  • 批准号:
    18390111
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.69万
  • 财政年份:
    2006
  • 负责人:
    WATANABE Toshiki
  • 依托单位:
国内基金
海外基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
  • 批准号:
    82371223
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    闻大翔
  • 依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
  • 批准号:
    82373139
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李孟鸿
  • 依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
  • 批准号:
    82372089
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李万万
  • 依托单位: